RxDoctor Payments Data

Jared Miller, MD

Psychiatry · Charleston, SCNPI 1891177333

Payments from drug & device makers

$3,271in general payments, 2019–2025

Across 173 payments — averaging $18.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$751
  • AbbVie$550
  • Otsuka America Pharmaceutical, Inc.$486
  • Neurocrine Biosciences, Inc.$444
  • E.r. Squibb & Sons, L.L.C.$261
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$209
  • plus $569 from 9 others

What the payments were for

  • Food & beverage$3,23599%
  • Education$361%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,271 in reported general payments places this provider in the 80th percentile of 624 psychiatry providers in South Carolina.

See all psychiatry providers in South Carolina

Medicare billing

Part B allowed, 2024
$20,230
Medicare patients
106
Services billed
374

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate111$381,950
Invega TrinzaPaliperidone Palmitate12$131,294
CaplytaLumateperone Tosylate52$91,245
AustedoDeutetrabenazine12$85,247
Abilify MaintenaAripiprazole30$75,895
AristadaAripiprazole Lauroxil20$49,504
BelsomraSuvorexant40$18,686
Clozapine173$14,425
Lurasidone Hcl90$12,803
Clozapine OdtClozapine15$9,952
Haloperidol Decanoate85$5,887
TrintellixVortioxetine Hydrobromide12$5,280
Fluvoxamine Maleate ErFluvoxamine Maleate11$4,969
Olanzapine OdtOlanzapine26$3,321
Olanzapine109$3,214

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Invega Trinza$751$513,245123 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$209$91,24552 claims
Teva Pharmaceuticals USA, Inc.Austedo$15$85,24712 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$486$75,89530 claims
Alkermes, Inc.Aristada$193$49,50420 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 624 psychiatry providers in South Carolina.

Other psychiatry in Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →